| Dr Nila A Shah, MD | |
|
68 W Cedar St, Poughkeepsie, NY 12601-1300 | |
| (845) 473-2122 | |
| (845) 471-1385 |
| Full Name | Dr Nila A Shah |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 68 W Cedar St, Poughkeepsie, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225154388 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 121811-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nila A Shah, MD 68 W Cedar St, Poughkeepsie, NY 12601-1300 Ph: (845) 473-2122 | Dr Nila A Shah, MD 68 W Cedar St, Poughkeepsie, NY 12601-1300 Ph: (845) 473-2122 |
News Archive
In an effort to study the interactions between genomics and Parkinson's disease, Cleveland Clinic has joined the ongoing efforts of 23andMe, a leading personal genetics company, to recruit Parkinson's patients to participate in research by contributing their DNA to a research database and completing online surveys about their health.
Deregulation and inhibition of the immune system contributes to cancer development. Many therapeutic strategies aim to restimulate the immune system to recognize cancer cells and target them for destruction.
Scientists from the University of Granada (UGR) have opened the door to the development of new drugs against osteoporosis, one of the most common chronic illnesses in the world, especially among women 65 or over.
The U.S. Food and Drug Administration has approved human clinical trials to test the safety of cancer-detection technology developed at Case Western Reserve University: a tumor-targeting contrast agent that accurately detects aggressive prostate cancer in a magnetic resonance imaging (MRI) scan.
New Phase III data found that investigational linagliptin therapy resulted in significant reductions in blood sugar as measured by hemoglobin A1c (HbA1c) when compared to placebo, both when added to sulfonylurea (SU) in inadequately controlled type 2 diabetes (T2D) patients, and when administered as monotherapy in T2D patients for whom metformin is inappropriate.
› Verified 5 days ago
Dr. Eldene Gwen Towey, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 241 North Rd # A, Poughkeepsie, NY 12601 Phone: 845-483-5000 | |
Sadaf R Ahsan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 241 North Rd, Poughkeepsie, NY 12601 Phone: 845-483-8743 Fax: 845-485-3809 | |
Dr. Karanjit Singh Parihar, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 241 North Rd # A, Poughkeepsie, NY 12601 Phone: 845-483-5000 | |
Gulnaz Kiyamova, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 241 North Rd, Poughkeepsie, NY 12601 Phone: 914-909-9018 Fax: 914-909-9028 | |
Dr. Thomas D Steeves, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 21 Reade Pl Ste 1100, Poughkeepsie, NY 12601 Phone: 845-214-1922 | |
Khaled I Mohamed, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 241 North Rd, Poughkeepsie, NY 12601 Phone: 845-431-8287 | |
Dr. Jihyuk Han, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 301 Manchester Road, Suite 203a, Poughkeepsie, NY 12603 Phone: 845-485-5000 Fax: 845-485-5002 |